Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
1 other identifier
interventional
68
1 country
1
Brief Summary
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) affects many adult men worldwide. So far, available therapies offer little or no proven benefit to CP/CPPS. The investigators design and implement this study is to assess efficacy of acupuncture therapy performed in the CP/CPPS .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2015
CompletedFirst Posted
Study publicly available on registry
October 27, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedFebruary 15, 2019
February 1, 2019
1.5 years
October 20, 2015
February 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NIH-CPSI total score and change from baseline
baseline, week 1-8
Secondary Outcomes (6)
NIH-CPSI subscales score
Baseline, week 4,8,20,32
NIH-CPSI total score in follow-up
week 20,32
IPSS total score and change from baseline
baseline, week 4,8,20,32
Global response assessment improvement
week 4,8,20,32
expectations degree
baseline
- +1 more secondary outcomes
Study Arms (2)
Acupuncture
EXPERIMENTALZhongliao (BL 33), Shenshu (BL 23), Huiyang (BL 35), and Sanyinjiao (SP 6) acupuncture points (Table 1). After patients are in prone position with relax, the investigators will use 75% alcohol pads to sterile the skin around the acupuncture points, and then insert steel needles (Huatuo, Suzhou, China 0.3mm\*40mm/0.3mm\*75mm) into the acupuncture points. For bilateral Zhongliao (BL 33), the needle will be inserted into about 50-60mm with 45 degree, for Huiyang (BL 35), the needle will be inserted into 50-60mm. for Shenshu (BL 23) and Sanyinjiao (SP 6), the needles will be inserted vertically to a depth of 25-30 mm. The treatment sessions are 24 after baseline, 3 times a week, and the each time the patients will accept a 30 minutes treatment.
placebo needle
PLACEBO COMPARATORThe participants in placebo needle group will receive placebo needle at the same acupuncture points to treatment group. Investigators will use a sort of blunt needle that cannot penetrate skin and stimulate deep tissues while the thrusting and twisting manipulation will be used by acupuncturists to mock the treatment procedure and blind the patients. The duration and frequency of sessions are same to the treatment group.
Interventions
Acupuncture is one of the oldest standardized neuromodulatory therapies. The method of acupuncture treatment involves the insertion of needles in acupuncture points according to a system of channels and meridians. The needles are stimulated by manual manipulation, electrical stimulation or heat. The general theory of acupuncture is based on the premise that there are patterns of energy flow through the body that are essential for health. Disruptions of this flow are believed to be responsible for disease. Acupuncture may correct imbalances of flow at identifiable points close to the skin.
Placebo needle is a type of control without skin penetration based on the application of placebo needles with blunt needle tips.
Eligibility Criteria
You may qualify if:
- History of pain perceived in the region of the prostate and absence of other lower urinary tract pathology for a minimum of 3 out of the past 6 months. In addition, associated lower urinary tract symptoms, sexual function, psychological factors should be addressed.
- Age 18 to 50 years
- NIH Chronic Prostatitis Symptom Index (NIH-CPSI) total score≥ 15 (scale 0-43, and 0 means no symptom).
You may not qualify if:
- Other urologic disease (for example, acute prostatitis, bacterial prostatitis, benign prostatic hyperplasia, prostate cancer, urinary tuberculosis, urinary tract infection)
- Serious or acute diseases with heart, liver, kidney and blood system.
- Patients who had received acupuncture or medication (including alpha-blockers or pain killers) treatment in the week prior to the baseline assessment
- Patients without telephone number who cannot be connected during the follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang'anmen Hospital, China Academy of Chinese Medical Science
Beijing, Beijing Municipality, 100053, China
Related Publications (1)
Qin Z, Zang Z, Wu J, Zhou J, Liu Z. Efficacy of acupuncture for chronic prostatitis/chronic pelvic pain syndromes: study protocol for a randomized, sham acupuncture-controlled trial. BMC Complement Altern Med. 2016 Nov 7;16(1):440. doi: 10.1186/s12906-016-1428-y.
PMID: 27821109DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhishun Liu, PhD
Guang'anmen Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of Department of Acupuncture
Study Record Dates
First Submitted
October 20, 2015
First Posted
October 27, 2015
Study Start
November 1, 2015
Primary Completion
May 1, 2017
Study Completion
November 1, 2017
Last Updated
February 15, 2019
Record last verified: 2019-02